ストックスクリーナーアプリを入手
13.72
0.29%
0.04
前日終値:
$13.68
開ける：
$13.72
24時間の取引高:
597.75K
Relative Volume:
0.61
時価総額：
$1.18B
収益：
$17.49M
当期純損益:
$-78.50M
株価収益率:
-11.43
EPS:
-1.2
ネットキャッシュフロー:
$-52.85M
1週間 パフォーマンス:
+10.73%
1か月 パフォーマンス:
-7.23%
6か月 パフォーマンス:
+19.72%
1年 パフォーマンス:
-1.01%
1日の値動き範囲:
$13.49
$14.06
1週間の範囲:
$12.24
$14.06
52週間の値動き範囲:
$8.26
$16.81
Liquidia Corp Stock (LQDA) Company Profile
名前
Liquidia Corp
セクター
電話
919.328.4400
住所
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
LQDA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
13.72 | 1.18B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-20 | 開始されました | Wells Fargo | Overweight |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-08-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | 開始されました | Raymond James | Outperform |
| 2024-06-25 | 開始されました | Oppenheimer | Perform |
| 2024-01-05 | 繰り返されました | Needham | Buy |
| 2022-09-19 | 再開されました | Wedbush | Underperform |
| 2022-09-01 | ダウングレード | Wedbush | Neutral → Underperform |
| 2022-07-22 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-05-31 | 開始されました | BTIG Research | Buy |
| 2022-05-26 | 開始されました | BofA Securities | Buy |
| 2020-12-04 | 開始されました | H.C. Wainwright | Buy |
| 2020-11-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-11-08 | 再開されました | Jefferies | Buy |
| 2018-09-05 | 開始されました | Wedbush | Outperform |
| 2018-08-20 | 開始されました | Jefferies | Buy |
| 2018-08-20 | 開始されました | Needham | Buy |
すべてを表示
Liquidia Corp (LQDA) 最新ニュース
Liquidia Corp’s chief medical officer sells $50,398 in stock By Investing.com - Investing.com Canada
Liquidia Corp Executives Sell Shares Under Rule 10b5-1 Plan - TradingView
Liquidia Corp’s chief medical officer sells $50,398 in stock - Investing.com
Liquidia Corp’s chief business officer Jason Adair sells shares worth $25,185 - Investing.com India
Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year - Yahoo Finance
Breaking Down Liquidia: 4 Analysts Share Their Views - Benzinga
Liquidia at Needham Conference: Strategic Insights on Eutropia Launch - Investing.com Australia
Liquidia at Needham Conference: Strategic Insights on Eutropia Launch By Investing.com - Investing.com India
Liquidia: United Therapeutics Has The Last Laugh (LQDA) - Seeking Alpha
Reviewing Praxis Precision Medicines (NASDAQ:PRAX) & Liquidia (NASDAQ:LQDA) - Defense World
UPDATELiquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - Yahoo Finance
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Liquidia Technologies (LQDA) Receives a Buy from Scotiabank - The Globe and Mail
Liquidia Co. (NASDAQ:LQDA) Receives $26.63 Average Price Target from Analysts - The AM Reporter
Liquidia says its request for Yutrepia final approval undergoes FDA review - MSN
Liquidia stock rises as Yutrepia undergoes FDA review (LQDA) - Seeking Alpha
FDA accepts Liquidia’s resubmission for YUTREPIA inhalation powder - Investing.com
Liquidia announces FDA acceptance of NDA resubmission for YUTREPIA - TipRanks
FDA accepts Liquidia’s resubmission for YUTREPIA inhalation powder By Investing.com - Investing.com Canada
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder - The Manila Times
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference - The Manila Times
Liquidia Corporation (NASDAQ:LQDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Liquidia (NASDAQ:LQDA) Price Target Raised to $34.00 - Defense World
Earnings To Watch: Liquidia Corp (LQDA) Reports Q4 2024 Result - GuruFocus.com
Scotiabank raises Liquidia stock target to $34 on Yutrepia prospects By Investing.com - Investing.com South Africa
What 4 Analyst Ratings Have To Say About Liquidia - Benzinga
Scotiabank raises Liquidia stock target to $34 on Yutrepia prospects - Investing.com
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Raymond James maintains strong buy on Liquidia stock, $27 target - Investing.com
H.C. Wainwright maintains Buy on Liquidia stock, $29 target - Investing.com
Raymond James maintains strong buy on Liquidia stock, $27 target By Investing.com - Investing.com UK
Liquidia Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Beyond the Balance Sheet: What SWOT Reveals About Liquidia Corp (LQDA) - GuruFocus
Earnings call transcript: Liquidia Technologies Q4 2024 misses revenue forecast - Investing.com
Liquidia Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Liquidia Corp Reports Annual EPS of -$1.66 and Revenue of $14.0 Million, Missing Estimates - GuruFocus.com
Liquidia Corp SEC 10-K Report - TradingView
Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update - TradingView
Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million - The Manila Times
When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? - Simply Wall St
Commit To Buy Liquidia At $7.50, Earn 11.3% Using Options - Nasdaq
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025 - The Manila Times
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025 - GlobeNewswire Inc.
Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) - GuruFocus.com
Liquidia (LQDA) to Release Earnings on Wednesday - The AM Reporter
Liquidia’s chief commercial officer sells shares worth $9,146 By Investing.com - Investing.com Canada
Liquidia’s chief commercial officer sells shares worth $9,146 - Investing.com India
Liquidia Corp CFO Michael Kaseta sells shares worth $13,503 - Investing.com
Liquidia Corp Executives Sell Shares - TradingView
Liquidia Corp (LQDA) 財務データ
収益
当期純利益
現金流量
EPS
Liquidia Corp (LQDA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| JEFFS ROGER | Chief Executive Officer |
Apr 14 '25 |
Sale |
13.57 |
14,130 |
191,744 |
1,006,420 |
| Moomaw Scott | Chief Commercial Officer |
Apr 15 '25 |
Sale |
13.57 |
3,406 |
46,219 |
214,744 |
| Kaseta Michael | CFO and COO |
Apr 14 '25 |
Sale |
13.57 |
8,283 |
112,400 |
396,315 |
| Saggar Rajeev | Chief Medical Officer |
Apr 14 '25 |
Sale |
13.57 |
3,714 |
50,399 |
265,602 |
| Adair Jason | Chief Business Officer |
Apr 14 '25 |
Sale |
13.57 |
1,856 |
25,186 |
184,304 |
| Schundler Russell | General Counsel |
Mar 03 '25 |
Sale |
15.45 |
930 |
14,368 |
576,265 |
| Moomaw Scott | Chief Commercial Officer |
Mar 03 '25 |
Sale |
15.45 |
592 |
9,146 |
218,150 |
| Kaseta Michael | CFO and COO |
Mar 03 '25 |
Sale |
15.45 |
874 |
13,503 |
404,598 |
| Adair Jason | Chief Business Officer |
Mar 03 '25 |
Sale |
15.45 |
451 |
6,968 |
182,254 |
| Adair Jason | Chief Business Officer |
Jan 27 '25 |
Sale |
14.20 |
445 |
6,319 |
179,770 |
2.51%
大文字化:
|
ボリューム (24 時間):